Latest Headlines

Similar Outcomes for IBD Patients Who Switch from Biosimilar to Originator

Similar Outcomes for IBD Patients Who Switch from Biosimilar to Originator

In a prospective observational study, patients who switched from treatment with a biosimilar to originator infliximab (Remicade) had outcomes...

Journal Reading List

Conversations with Experts

click me